Cargando…
The Efficacy of the BCG Vaccine against Newly Emerging Clinical Strains of Mycobacterium tuberculosis
To date, most new vaccines against Mycobacterium tuberculosis, including new recombinant versions of the current BCG vaccine, have usually been screened against the laboratory strains H37Rv or Erdman. In this study we took advantage of our recent work in characterizing an increasingly large panel of...
Autores principales: | Henao-Tamayo, Marcela, Shanley, Crystal A., Verma, Deepshikha, Zilavy, Andrew, Stapleton, Margaret C., Furney, Synthia K., Podell, Brendan, Orme, Ian M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569086/ https://www.ncbi.nlm.nih.gov/pubmed/26368806 http://dx.doi.org/10.1371/journal.pone.0136500 |
Ejemplares similares
-
GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis
por: King, Thomas H., et al.
Publicado: (2017) -
Biology of clinical strains of Mycobacterium tuberculosis with varying levels of transmission
por: Shanley, Crystal A., et al.
Publicado: (2018) -
Trying to See the Forest through the Trees: Deciphering the Nature of Memory Immunity to Mycobacterium tuberculosis
por: Orme, Ian M., et al.
Publicado: (2018) -
Mouse Subcutaneous BCG Vaccination and Mycobacterium tuberculosis Infection Alter the Lung and Gut Microbiota
por: Silva, Fabiola, et al.
Publicado: (2022) -
Gr1(int)CD11b(+) Myeloid-Derived Suppressor Cells in Mycobacterium tuberculosis Infection
por: Obregón-Henao, Andrés, et al.
Publicado: (2013)